Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16

Published:2018-09-19 Issue: Volume:9 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Tyurenkov Ivan N.,Kurkin Denis V.,Bakulin Dmitry A.,Volotova Elena V.,Morkovin Evgeny I.,Chafeev Mikhail A.,Karapetian Ruben N.

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference41 articles.

1. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells;Ning;Br J Pharmacol,2008

2. Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues;Henquin;Diabetes,2004

3. GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity;Fyfe;Expert Opin Drug Discov.,2008

4. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release;Chu;Endocrinology,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23

2. Physiology and pharmacology of glucagon-like peptide-1 receptor;Pharmacy & Pharmacology;2024-01-09

3. Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review;Mini-Reviews in Medicinal Chemistry;2023-11

4. Therapeutic charisma of imidazo [2,1-b] [1,3,4]-thiadiazole analogues: a patent review;Pharmaceutical Patent Analyst;2023-07

5. From Molecule to Drug. Pharmaceutical Logistics Approach;Annals of the Russian academy of medical sciences;2023-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3